Proteomics in discovery of hepatocellular carcinoma biomarkers

被引:0
|
作者
Wu Cheng [1 ]
Li Song-Tao [2 ]
Liu Li-Jie [1 ]
Wang Zhan-Feng
Lu Jun-Hua [3 ]
Liu Bao-Hai [1 ]
Liao Ping [4 ]
Wang Wen-Jing [4 ]
Zhu Liang [1 ]
机构
[1] Second Mil Med Univ, Dept Gastroenterol, Affiliated Hosp 2, Shanghai 200043, Peoples R China
[2] Second Mil Med Univ, Dept Surg, Eastern Hepatobiliary Surg Hosp, Shanghai 200043, Peoples R China
[3] China Sci & Technol Univ, Dept Stat & Finance, Beijing, Peoples R China
[4] Shanghai Municipal Ctr, Dept Publ Hlth & Mol Biol, Shanghai, Peoples R China
关键词
proteomics; biomarker; hepatocellular carcinoma;
D O I
10.1007/s11670-007-0159-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To discover new proteomic biomarkers of hepatocellular carcinoma. Methods: Surface enhanced laser desorption/ionization time-of-flight (SELDI-TOF) mass spectrometry was used to discover biomarkers for differentiating hepatocellular carcinoma and chronic liver disease. A population of 50 patients with hepatocellular carcinoma and 33 patients with chronic liver disease was studied. Results: Twelve proteomic biomarkers of hepatocellular carcinoma were detected in this study. Three proteomic biomarkers were highly expressed in hepatocellular carcinoma and nine proteomic biomarkers were highly expressed in chronic liver disease. The most valuable proteomic biomarker with m/z=11498 had no similar diagnostic value as alpha-fetoprotein. Conclusion: Some of the twelve proteomic biomarkers may become new biomarkers of hepatocellular carcinoma.
引用
收藏
页码:159 / 164
页数:6
相关论文
共 50 条
  • [31] PROTEOMICS A discovery strategy for novel cancer biomarkers
    Swami, Meera
    NATURE REVIEWS CANCER, 2010, 10 (09) : 597 - 597
  • [32] The biomarkers discovery of hyperuricemia and gout: proteomics and metabolomics
    Wu, Xinghong
    You, Chongge
    PEERJ, 2023, 11
  • [33] Discovery of biomarkers for gastric cancer: A proteomics approach
    Lin, Li-Ling
    Huang, Hsuan-Cheng
    Juan, Hsueh-Fen
    JOURNAL OF PROTEOMICS, 2012, 75 (11) : 3081 - 3097
  • [34] The biomarkers discovery of hyperuricemia and gout: proteomics and metabolomics
    Wu, Xinghong
    You, Chongge
    PEERJ, 2023, 11
  • [35] Proteomics in Cancer Biomarkers Discovery: Challenges and Applications
    Sallam, Reem M.
    DISEASE MARKERS, 2015, 2015 : 1 - 12
  • [36] Application of Proteomics in the Discovery of Radiosensitive Cancer Biomarkers
    Luo, Hui
    Ge, Hong
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [37] Proteomics of metabolic staging of hepatocellular carcinoma
    Wang, R.
    Yang, H.
    Llovet, J. M.
    MOLECULAR & CELLULAR PROTEOMICS, 2006, 5 (10) : S211 - S211
  • [38] Biomarker discovery of nasopharyngeal carcinoma by proteomics
    Xiao, Liang
    Xiao, Ta
    Wang, Zhi-Ming
    Cho, William C. S.
    Xiao, Zhi-Qiang
    EXPERT REVIEW OF PROTEOMICS, 2014, 11 (02) : 215 - 225
  • [39] Hepatocellular carcinoma: From bedside to proteomics
    Seow, TK
    Liang, RCMY
    Leow, CK
    Chung, MCM
    PROTEOMICS, 2001, 1 (10) : 1249 - 1263
  • [40] Proteomics of Hepatocellular Carcinoma in Chinese Patients
    Luk, John M.
    Liu, Angela M.
    OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2011, 15 (05) : 261 - 266